The terms of the agreement include: a co-exclusive license to co-commercialize
(C) 2024 Electronic News Publishing, source
Market Closed -
Other stock markets
|
Pre-market 02:13:08 am | |||
90.27 EUR | -0.94% | 90.89 | +0.69% |
Jun. 10 | Latest trial over Zantac cancer claims called off as plaintiff drops case | RE |
Jun. 10 | Moderna COVID/flu combo vaccine superior to separate shots in trial | RE |
The terms of the agreement include: a co-exclusive license to co-commercialize
(C) 2024 Electronic News Publishing, source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
90.27 EUR | -0.94% | +0.18% | 121B | ||
16 USD | -11.92% | -12.16% | 2.25B | ||
1st Jan change | Capi. | |
---|---|---|
+0.57% | 121B | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.87% | 249B | |
-1.96% | 216B | |
+11.11% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |